Here we consider whether clinical circumstances point to a role for antibodies with poor or no neutralizing activity in severe COVID-19, incorporating relevant experience from disease caused by the common human coronaviruses, as well as by severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome-related coronavirus (MERS-CoV)
Are vitamin B12 shots right for you
Glutathione is more expensive that NAC
doi: 10.3389/fenvs.2024.1514062 Received 19 October 2024 Accepted 13 December 2024 Published 06 January 2025 Volume 12 - 2024 Edited by Ping Li, Shandong University, Weihai, China Reviewed by Mohamed Ahmed Ibrahim Ahmed, Assiut University, Egypt Jiawei Li, Southern University of Science and Technology, China Updates Copyright 2025 Elas, Ramirez Vieytez, Funoy Sayar, Loaisiga, Harper and Doll